TP53 and intestinal neoplasm: In this study, we used mouse intestinal tumor–derived organoids that carried Apc, Kras, and Tgfbr2 mutations together with Trp53R270H or Trp53−/− mutation to identify a tumor-promoting mechanism of mutant p53 and interaction between mutant p53-stabilized and -destabilized cells.